The state company sold Viktor Kharitonin a stake in PET-technology.
His Cypriot company Augment Investments, which owns the main producer of arbidol in Russia - Otisipharm, as well as Pharmstandard, is being liquidated.
The former shareholder of Pharmstandard has now become the largest shareholder of the British start-up CMR. The enterprise plans to compete with already existing robots-surgeons da Vinci.
Minorities of "Pharmstandard" have seized from the main owners of the company 540 million rubles.